ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALXO ALX Oncology Holdings

交易中 07-18 10:25:47 EDT

7.41

-0.25

-3.26%

最高7.77	最低7.40	成交量5.83万
今开7.66	昨收7.66	日振幅4.90%
总市值3.86亿	流通市值1.58亿	总股本5,210万
成交额44.48万	换手率0.27%	流通股本2,135万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALXO","market":"US","secType":"STK","nameCN":"ALX Oncology Holdings","latestPrice":7.41,"timestamp":1721312735209,"preClose":7.66,"halted":0,"volume":58305,"delay":0,"floatShares":21347091,"shares":52100107,"eps":-3.668729,"marketStatus":"交易中","marketStatusCode":2,"change":-0.25,"latestTime":"07-18 10:25:47 EDT","open":7.66,"high":7.77,"low":7.395,"amount":444805.7723265,"amplitude":0.048956,"askPrice":7.44,"askSize":10,"bidPrice":7.38,"bidSize":83,"shortable":3,"etf":0,"ttmEps":-3.668729,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721332800000},"adr":0,"listingDate":1594958400000,"adjPreClose":7.66,"postHourTrading":{"tag":"盘后","latestPrice":7.66,"preClose":7.66,"latestTime":"18:37 EDT","volume":89663,"amount":686817.19,"timestamp":1721255826170},"volumeRatio":0.335632,"impliedVol":1.6026,"impliedVolPercentile":0.9484},"requestUrl":"/m/hq/s/ALXO","defaultTab":"news","newsList":[{"id":"2452165867","title":"Alx Oncology Holdings Inc.盘中异动 急速跳水5.04%报7.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452165867","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452165867?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:40","pubTimestamp":1721227221,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时40分，Alx Oncology Holdings Inc.股票出现异动，股价急速跳水5.04%。截至发稿，该股报7.72美元/股，成交量8.233万股，换手率0.16%，振幅4.18%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为1.89%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717224021af92cc40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717224021af92cc40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2451915181","title":"Alx Oncology Holdings Inc.盘中异动 大幅拉升5.00%报8.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451915181","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451915181?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:15","pubTimestamp":1721139358,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时15分，Alx Oncology Holdings Inc.股票出现异动，股价急速上涨5.00%。截至发稿，该股报8.40美元/股，成交量13.9913万股，换手率0.27%，振幅7.00%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716221558af929aaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716221558af929aaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2451671269","title":"Alx Oncology Holdings Inc.盘中异动 大幅拉升5.38%报7.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451671269","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451671269?lang=zh_cn&edition=full","pubTime":"2024-07-16 02:37","pubTimestamp":1721068679,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日02时37分，Alx Oncology Holdings Inc.股票出现异动，股价快速拉升5.38%。截至发稿，该股报7.44美元/股，成交量44.0721万股，换手率0.85%，振幅6.80%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716023759af926b69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716023759af926b69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2451555915","title":"Alx Oncology Holdings Inc.盘中异动 股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451555915","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451555915?lang=zh_cn&edition=full","pubTime":"2024-07-13 00:26","pubTimestamp":1720801604,"startTime":"0","endTime":"0","summary":"北京时间2024年07月13日00时26分，Alx Oncology Holdings Inc.股票出现异动，股价大幅跳水5.45%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.24%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。消息层面，截至00时26分，《派杰投资维持ALX Oncology买入评级，维持目标价21美元》资讯为影响Alx Oncology Holdings Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713002644aef97ead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713002644aef97ead&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2450365967","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450365967","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450365967?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:03","pubTimestamp":1720706611,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时03分，Alx Oncology Holdings Inc.股票出现异动，股价快速上涨5.10%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。消息层面，截至22时03分，《派杰投资维持ALX Oncology买入评级，维持目标价21美元》资讯为影响Alx Oncology Holdings Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220332af91dee0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220332af91dee0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2450814671","title":"Alx Oncology Holdings Inc.盘中异动 早盘急速拉升5.19%报6.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450814671","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450814671?lang=zh_cn&edition=full","pubTime":"2024-07-10 23:08","pubTimestamp":1720624091,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日23时08分，Alx Oncology Holdings Inc.股票出现异动，股价大幅拉升5.19%。截至发稿，该股报6.69美元/股，成交量22.2868万股，换手率0.43%，振幅5.19%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.35%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710230811aef90052&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710230811aef90052&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRPX","BK4139","ALXO","LGVN","BK4007"],"gpt_icon":0},{"id":"2450733030","title":"Alx Oncology Holdings Inc.盘中异动 下午盘股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450733030","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450733030?lang=zh_cn&edition=full","pubTime":"2024-07-10 01:00","pubTimestamp":1720544414,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日01时00分，Alx Oncology Holdings Inc.股票出现异动，股价大幅上涨5.32%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710010015af916026&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710010015af916026&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2449370705","title":"Alx Oncology Holdings Inc.盘中异动 早盘大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449370705","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449370705?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:38","pubTimestamp":1720445912,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时38分，Alx Oncology Holdings Inc.股票出现异动，股价大幅拉升5.14%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213832af911624&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213832af911624&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2448893884","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨5.24%报6.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448893884","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448893884?lang=zh_cn&edition=full","pubTime":"2024-07-03 22:14","pubTimestamp":1720016090,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日22时14分，Alx Oncology Holdings Inc.股票出现波动，股价急速拉升5.24%。截至发稿，该股报6.02美元/股，成交量8.9882万股，换手率0.17%，振幅5.33%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703221450aef7cb4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703221450aef7cb4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2446529105","title":"Alx Oncology Holdings Inc.盘中异动 早盘急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446529105","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446529105?lang=zh_cn&edition=full","pubTime":"2024-06-27 23:14","pubTimestamp":1719501254,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日23时14分，Alx Oncology Holdings Inc.股票出现波动，股价大幅上涨5.10%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。消息层面，截至23时14分，《ALX OncologyGARCIA PETER S增持1.2万股普通股股份，价值约10.23万美元》资讯为影响Alx Oncology Holdings Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627231414aef6f369&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627231414aef6f369&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2446396639","title":"Alx Oncology Holdings Inc.盘中异动 急速下跌6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446396639","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446396639?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:34","pubTimestamp":1719408885,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时34分，Alx Oncology Holdings Inc.股票出现波动，股价快速下挫6.09%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。消息层面，截至21时34分，《ALX OncologyGARCIA PETER S增持1.2万股普通股股份，价值约10.23万美元》资讯为影响Alx Oncology Holdings Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406262134459681714d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406262134459681714d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2446322849","title":"Alx Oncology Holdings Inc.盘中异动 快速下跌5.04%报6.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446322849","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446322849?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:34","pubTimestamp":1719322456,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时34分，Alx Oncology Holdings Inc.股票出现异动，股价快速下挫5.04%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。消息层面，截至21时34分，《ALX OncologyGARCIA PETER S增持1.2万股普通股股份，价值约10.23万美元》资讯为影响Alx Oncology Holdings Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521341696816a1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521341696816a1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2444245336","title":"Alx Oncology Holdings Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444245336","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444245336?lang=zh_cn&edition=full","pubTime":"2024-06-19 00:40","pubTimestamp":1718728844,"startTime":"0","endTime":"0","summary":"北京时间2024年06月19日00时40分，Alx Oncology Holdings Inc.股票出现异动，股价急速跳水5.15%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619004045941ef447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619004045941ef447&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2444167902","title":"Alx Oncology Holdings Inc.盘中异动 急速拉升5.03%报8.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444167902","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444167902?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:31","pubTimestamp":1718631078,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时31分，Alx Oncology Holdings Inc.股票出现异动，股价大幅拉升5.03%。截至发稿，该股报8.46美元/股，成交量2.2748万股，换手率0.04%，振幅0.99%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406172131199f469904&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406172131199f469904&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2443651606","title":"Alx Oncology Holdings Inc.盘中异动 下午盘急速跳水5.21%报8.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443651606","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443651606?lang=zh_cn&edition=full","pubTime":"2024-06-15 01:57","pubTimestamp":1718387848,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日01时57分，Alx Oncology Holdings Inc.股票出现波动，股价快速下挫5.21%。截至发稿，该股报8.00美元/股，成交量18.7581万股，换手率0.36%，振幅4.38%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615015729aef50d32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615015729aef50d32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2442855426","title":"Alx Oncology Holdings Inc.盘中异动 快速拉升5.02%报8.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442855426","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442855426?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:32","pubTimestamp":1718199140,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时32分，Alx Oncology Holdings Inc.股票出现波动，股价大幅拉升5.02%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。消息层面，截至21时32分，《H.C. Wainwright维持ALX Oncology买入评级，维持目标价25美元》资讯为影响Alx Oncology Holdings Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213220941ee0c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213220941ee0c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2441272267","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨6.09%报8.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441272267","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441272267?lang=zh_cn&edition=full","pubTime":"2024-06-05 22:22","pubTimestamp":1717597360,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日22时22分，Alx Oncology Holdings Inc.股票出现波动，股价快速拉升6.09%。截至发稿，该股报8.88美元/股，成交量7.5771万股，换手率0.15%，振幅4.54%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605222240af8c2a25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605222240af8c2a25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2440349905","title":"Alx Oncology Holdings Inc.盘中异动 大幅下挫5.03%报10.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440349905","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440349905?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:32","pubTimestamp":1717425169,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日22时32分，Alx Oncology Holdings Inc.股票出现波动，股价快速下跌5.03%。截至发稿，该股报10.10美元/股，成交量21.6055万股，换手率0.41%，振幅7.90%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.45%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603223249af8bb6e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603223249af8bb6e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2439586876","title":"Alx Oncology Holdings Inc.盘中异动 下午盘急速下挫5.01%报12.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439586876","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439586876?lang=zh_cn&edition=full","pubTime":"2024-05-29 02:01","pubTimestamp":1716919286,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日02时01分，Alx Oncology Holdings Inc.股票出现异动，股价大幅下跌5.01%。截至发稿，该股报12.51美元/股，成交量21.1398万股，换手率0.41%，振幅6.61%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为2.00%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529020126968104a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529020126968104a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2438052484","title":"Alx Oncology Holdings Inc.盘中异动 急速跳水5.85%报13.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438052484","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438052484?lang=zh_cn&edition=full","pubTime":"2024-05-24 23:51","pubTimestamp":1716565908,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日23时51分，Alx Oncology Holdings Inc.股票出现异动，股价大幅下跌5.85%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。消息层面，截至23时51分，《斯迪富维持ALX Oncology持有评级，维持目标价14美元》资讯为影响Alx Oncology Holdings Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524235149af8a2fc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524235149af8a2fc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alxoncology.com","stockEarnings":[{"period":"1week","weight":0.1331},{"period":"1month","weight":0.0379},{"period":"3month","weight":-0.5133},{"period":"6month","weight":-0.4245},{"period":"1year","weight":0.1053},{"period":"ytd","weight":-0.4856}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":0.018},{"period":"3month","weight":0.115},{"period":"6month","weight":0.1544},{"period":"1year","weight":0.2262},{"period":"ytd","weight":0.1717}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ALX Oncology Holdings Inc.于2020年4月1日成立。该公司是一家临床阶段免疫肿瘤学公司，致力于通过开发阻断CD47检查点通路并连接先天性和适应性免疫系统的疗法，帮助患者抗癌。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.135783},{"month":2,"riseRate":0.75,"avgChangeRate":-0.031126},{"month":3,"riseRate":0,"avgChangeRate":-0.176518},{"month":4,"riseRate":0.5,"avgChangeRate":0.111643},{"month":5,"riseRate":0.25,"avgChangeRate":-0.187435},{"month":6,"riseRate":0.5,"avgChangeRate":-0.07132},{"month":7,"riseRate":0.75,"avgChangeRate":0.087848},{"month":8,"riseRate":0.75,"avgChangeRate":0.118061},{"month":9,"riseRate":0.5,"avgChangeRate":-0.037177},{"month":10,"riseRate":0.75,"avgChangeRate":0.143545},{"month":11,"riseRate":0.5,"avgChangeRate":0.13105},{"month":12,"riseRate":0.75,"avgChangeRate":0.175818}],"exchange":"NASDAQ","name":"ALX Oncology Holdings","nameEN":"ALX Oncology Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ALX Oncology Holdings(ALXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ALX Oncology Holdings,ALXO,ALX Oncology Holdings股票,ALX Oncology Holdings股票老虎,ALX Oncology Holdings股票老虎国际,ALX Oncology Holdings行情,ALX Oncology Holdings股票行情,ALX Oncology Holdings股价,ALX Oncology Holdings股市,ALX Oncology Holdings股票价格,ALX Oncology Holdings股票交易,ALX Oncology Holdings股票购买,ALX Oncology Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ALX Oncology Holdings(ALXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}